These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20718109)

  • 21. [Effect of a new 10% hydroxyethyl starch solution HES/270/0.5 on blood coagulation, blood loss and hemodynamics in comparison with 3.5% PPL].
    Penner M; Fingerhut D; Tacke A
    Infusionstherapie; 1990 Dec; 17(6):314-8. PubMed ID: 1709146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The new-generation hydroxyethyl starch solutions: the Holy Grail of fluid therapy or just another starch?
    Murphy GS; Greenberg SB
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):389-93. PubMed ID: 20399119
    [No Abstract]   [Full Text] [Related]  

  • 23. Attenuation of capillary leakage by hydroxyethyl starch (130/0.42) in a porcine model of septic shock.
    Marx G; Pedder S; Smith L; Swaraj S; Grime S; Stockdale H; Leuwer M
    Crit Care Med; 2006 Dec; 34(12):3005-10. PubMed ID: 16971858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hydroxyethyl starch--a new interesting colloidal plasma volume expander. Anaphylactoid reactions (author's transl)].
    Seidemann J
    Zentralbl Chir; 1979; 104(22):1457-64. PubMed ID: 95073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery.
    Boldt J; Schöllhorn T; Münchbach J; Pabsdorf M
    Eur J Anaesthesiol; 2007 Mar; 24(3):267-75. PubMed ID: 17054812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of crystalloid and colloid resuscitation on hemorrhage-induced vascular hyporesponsiveness to norepinephrine in the rat.
    Liu LM; Ward JA; Dubick MA
    J Trauma; 2003 May; 54(5 Suppl):S159-68. PubMed ID: 12768120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volume replacement in critically ill patients with acute renal failure.
    Ragaller MJ; Theilen H; Koch T
    J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S33-9. PubMed ID: 11251029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactated Ringer's solution versus hydroxyethyl starch for volume replacement in autologous blood donors with cardiovascular disease: a controlled, randomized trial.
    Kasper SM; Dahlmann H; Mellinghoff H; Ellering J; Baumann M; Buzello W
    Vox Sang; 1998; 75(1):26-31. PubMed ID: 9745150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of hetastarch for plasma expansion.
    Smiley LE
    Probl Vet Med; 1992 Dec; 4(4):652-67. PubMed ID: 1282053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new hydroxyethyl starch for volume replacement: Elohes 6%].
    Medel J; Baron JF
    Rev Esp Anestesiol Reanim; 1998 Nov; 45(9):389-96. PubMed ID: 9847657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colloid preload versus coload for spinal anesthesia for cesarean delivery: the effects on maternal cardiac output.
    Teoh WH; Sia AT
    Anesth Analg; 2009 May; 108(5):1592-8. PubMed ID: 19372341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass.
    Sade RM; Stroud MR; Crawford FA; Kratz JM; Dearing JP; Bartles DM
    J Thorac Cardiovasc Surg; 1985 May; 89(5):713-22. PubMed ID: 2581099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of plasma volume expanders.
    Farrugia A
    J Clin Pharmacol; 2011 Mar; 51(3):292-300. PubMed ID: 20501941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Doubts about HES. The European Medicines Agency withdraws the marketing permit until further notice].
    Svensén C
    Lakartidningen; 2013 Aug 7-20; 110(32-33):1399. PubMed ID: 23980378
    [No Abstract]   [Full Text] [Related]  

  • 36. Toxic effects of colloids in the intensive care unit.
    Nearman HS; Herman ML
    Crit Care Clin; 1991 Jul; 7(3):713-23. PubMed ID: 1713807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hetastarch use in bariatric surgery: word of caution.
    Chan T; Conovaloff C; Mehran A
    Am Surg; 2012 May; 78(5):E278-9. PubMed ID: 22546105
    [No Abstract]   [Full Text] [Related]  

  • 38. The Scandinavian Critical Care Trials Group: producing important new findings in challenging times.
    Flaatten H; Haney M; Wernerman J
    Acta Anaesthesiol Scand; 2013 Feb; 57(2):138-40. PubMed ID: 23294054
    [No Abstract]   [Full Text] [Related]  

  • 39. Hetastarch: an alternative colloid in burn shock management.
    Waters LM; Christensen MA; Sato RM
    J Emerg Nurs; 1990; 16(4):279-87. PubMed ID: 2385063
    [No Abstract]   [Full Text] [Related]  

  • 40. Hydroxyethyl starches: what do we still know?
    Reinhart K; Takala J
    Anesth Analg; 2011 Mar; 112(3):507-11. PubMed ID: 21296859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.